Literature DB >> 35089537

Significance of regulatory T cells in children with idiopathic nephrotic syndrome.

Shoji Tsuji1, Tadashi Yamaguchi1, Yuko Akagawa1, Shohei Akagawa1, Sohsaku Yamanouchi1, Takahisa Kimata1, Kazunari Kaneko2.   

Abstract

Entities:  

Keywords:  Biomarker; CD80; Idiopathic nephrotic syndrome; Podocyte; Regulatory T cell

Mesh：

Year:  2022        PMID： 35089537     DOI： 10.1007/s40620-021-01201-z

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  5 in total

Review 1.  Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome.

Authors:  Jochen Reiser; Peter Mundel
Journal:  J Am Soc Nephrol       Date:  2004-09       Impact factor: 10.121

2.  Minimal change disease: a "two-hit" podocyte immune disorder?

Authors:  Michiko Shimada; Carlos Araya; Chris Rivard; Takuji Ishimoto; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2010-10-30       Impact factor: 3.714

3.  Rituximab modulates T- and B-lymphocyte subsets and urinary CD80 excretion in patients with steroid-dependent nephrotic syndrome.

Authors:  Divya Bhatia; Aditi Sinha; Pankaj Hari; Shailaja Sopory; Savita Saini; Mamta Puraswani; Himanshi Saini; Dipendra K Mitra; Arvind Bagga
Journal:  Pediatr Res       Date:  2018-07-09       Impact factor: 3.756

4.  Urinary CD80 excretion increases in idiopathic minimal-change disease.

Authors:  Eduardo H Garin; Leila N Diaz; Wei Mu; Clive Wasserfall; Carlos Araya; Mark Segal; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

5.  Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.

Authors:  Gabriel Cara-Fuentes; Madhusudan Venkatareddy; Rakesh Verma; Alfons Segarra; Audrey C Cleuren; Alfonso Martínez-Ramos; Richard J Johnson; Puneet Garg
Journal:  Pediatr Nephrol       Date:  2020-05-12       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.